BioSyent Inc.
RX.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 6.18M | 5.92M | 5.62M | 5.31M | 5.23M |
| Total Depreciation and Amortization | 774.50K | 675.80K | 655.60K | 597.00K | 228.00K |
| Total Amortization of Deferred Charges | 10.80K | 48.40K | 3.90K | 700.00 | 121.20K |
| Total Other Non-Cash Items | 170.90K | 150.20K | 109.70K | -69.70K | -564.80K |
| Change in Net Operating Assets | -1.07M | 2.09M | -1.11M | 644.00K | -69.00K |
| Cash from Operations | 5.89M | 8.72M | 5.11M | 6.31M | 4.94M |
| Capital Expenditure | -41.50K | -59.90K | -52.40K | -40.80K | -48.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.51M | -1.50M | 3.60M | 3.05M | 1.12M |
| Cash from Investing | 1.83M | -2.19M | 2.92M | 2.38M | 1.08M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -191.50K | -188.10K | -185.70K | -183.20K | -180.80K |
| Issuance of Common Stock | 261.40K | 277.20K | 308.90K | 250.40K | 155.10K |
| Repurchase of Common Stock | -4.78M | -4.79M | -5.14M | -5.76M | -2.79M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.57M | -1.55M | -1.52M | -1.52M | -1.50M |
| Other Financing Activities | -51.80K | -54.30K | -56.70K | -59.20K | -61.60K |
| Cash from Financing | -4.96M | -4.93M | -5.13M | -5.68M | -3.62M |
| Foreign Exchange rate Adjustments | 21.90K | -2.10K | 3.10K | 3.70K | -130.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.78M | 1.60M | 2.90M | 3.02M | 2.26M |